Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2017.1395020
Abstract: ABSTRACT Introduction: Despite type 2 diabetes (T2D) being recognized as a bihormonal pancreatic disease, current therapies are mainly focusing on insulin, while targeting glucagon has been long dismissed. However, glucagon receptor (GCGr) antagonists are currently… read more here.
Keywords: gcgr antagonists; antagonists phase; glucagon receptor; clinical trials ... See more keywords